CoChat

Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial

Open access
de Jager, Rosa L., de Beus, Esther, Beeftink, Martine M.A., Sanders, Margreet F., Vonken, Evert-Jan, Voskuil, Michiel, van Maarseveen, Erik M., Bots, Michiel L., Blankestijn, Peter J. · 2017 · Hypertension
Cited by 83

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Randomized trials of catheter-based renal denervation (RDN) as therapy for resistant hypertension showed conflicting results in blood pressure (BP) lowering effect. Adherence to medication is modest in this patient group and may importantly drive these conflicting results. SYMPATHY is a prospective open label multicenter trial in Dutch patients with resistant hypertension. Primary outcome was change in daytime systolic ambulatory BP at 6 months. Patients were randomly assigned to RDN on top of usual care. Adherence to BP lowering drugs was assessed at baseline and follow-up, using blood samples drawn synchronously with BP measurements. Patients and physicians were unaware of the adherence assessment. Primary analyses showed a mean difference between RDN (n=95) and control (n=44) in changes in daytime systolic ambulatory BP after 6 months of 2.0 mm Hg (95% confidence interval, −6.1 to 10.2 mm Hg) in favor of control. In 80% of patients, fewer medications were detected than prescribed and adherence changed during follow-up in 31%. In those with stable adherence during follow-up, mean difference between RDN and control for daytime systolic ambulatory BP was −3.3 mm Hg (−13.7 to 7.2 mm Hg) in favor of RDN. RDN as therapy for resistant hypertension was not superior to usual care. Objective assessment of medication use shows that medication adherence is extremely poor, when patients are unaware of monitoring. Changes over time in adherence are common and affect treatment estimates considerably. Objective measurement of medication adherence during follow-up is strongly recommended in randomized trials. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT01850901.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.116.08818

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 83

Metadata

Authors
de Jager, R. L., de Beus, E., Beeftink, M. M. A., Sanders, M. F., Vonken, E.-J., Voskuil, M., van Maarseveen, E. M., Bots, M. L., & Blankestijn, P. J.
Venue
Hypertension
Published
2017-04
Volume
69
Issue
4
Pages
678-684
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2764238114
Cited by
83
References
6
FWCI
8.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. https://app.cochat.ai/papers/10.1161/hypertensionaha.116.08818
The paper
de Jager, R. L., de Beus, E., Beeftink, M. M. A., Sanders, M. F., Vonken, E.-J., Voskuil, M., van Maarseveen, E. M., Bots, M. L., & Blankestijn, P. J. (2017). Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. Hypertension. https://doi.org/10.1161/hypertensionaha.116.08818

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.